• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞舒伐他汀通过调节 PIM1 抑制卵巢癌的肿瘤生长和糖酵解。

Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1.

机构信息

Department of Gynecology, Jining No. 1 People's Hospital, Jining, Shandong, China.

Department of Interventional Radiology, Qingdao Hospital of Traditional Chinese Medicine, Qingdao, Shandong, China.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2019 Dec;392(12):1477-1489. doi: 10.1007/s00210-019-01687-2. Epub 2019 Jul 10.

DOI:10.1007/s00210-019-01687-2
PMID:31292669
Abstract

Ovarian cancer is a common human malignancy of the female reproductive system. However, chemotherapy has been proven to have limited effectiveness in a majority of patients. Resibufogenin (RB) is a major active ingredient in cinobufacini, which has been used in the treatment of human malignancies as adjunct agents. This study was designed to examine the anti-cancer effect of RB and the underlying mechanisms in ovarian cancer. Our results showed that RB treatment resulted in cell death, cell cycle arrest, and apoptosis in ovarian cancer cells. The anti-growth and pro-apoptotic effects of RB were also validated in xenograft mice models. Proteomics analysis indicated that RB was able to alter the expressions of several genes, which were involved in the regulation of glycolysis. The suppression effect of RB in the glycolysis pathway of ovarian cancer cells was validated by decreased glucose consumption, lactate production, and extracellular acidification rate (ECAR). We proposed that PIM1 functioned as the key target that mediated the anti-cancer effect of RB against ovarian cancer cells. Our results have revealed that RB downregulated PIM1 in ovarian cancer cells and its downstream genes involved in glycolysis. Moreover, our results indicated that the anti-growth activities and suppressing effect of RB on glycolysis were enhanced significantly by PIM1 knockdown but was attenuated by ectopic PIM1 expression. This provided evidence to support the role of PIM1 in the anti-cancer activities of RB.

摘要

卵巢癌是女性生殖系统常见的恶性肿瘤。然而,化疗已被证明对大多数患者的疗效有限。沙蟾毒精是华蟾素的主要活性成分之一,已被用作治疗人类恶性肿瘤的辅助药物。本研究旨在探讨沙蟾毒精对卵巢癌细胞的抗癌作用及其作用机制。我们的结果表明,沙蟾毒精处理导致卵巢癌细胞死亡、细胞周期停滞和凋亡。沙蟾毒精在异种移植小鼠模型中的抗生长和促凋亡作用也得到了验证。蛋白质组学分析表明,沙蟾毒精能够改变参与糖酵解调控的几个基因的表达。沙蟾毒精对卵巢癌细胞糖酵解途径的抑制作用通过降低葡萄糖消耗、乳酸生成和细胞外酸化率(ECAR)得到验证。我们提出 PIM1 作为介导沙蟾毒精对卵巢癌细胞抗癌作用的关键靶标。我们的结果表明,沙蟾毒精在卵巢癌细胞中下调了 PIM1 及其下游参与糖酵解的基因。此外,我们的结果表明,PIM1 敲低显著增强了沙蟾毒精的抗生长活性和对糖酵解的抑制作用,而外源性 PIM1 表达则减弱了这种作用。这为 PIM1 在沙蟾毒精抗癌活性中的作用提供了证据支持。

相似文献

1
Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1.瑞舒伐他汀通过调节 PIM1 抑制卵巢癌的肿瘤生长和糖酵解。
Naunyn Schmiedebergs Arch Pharmacol. 2019 Dec;392(12):1477-1489. doi: 10.1007/s00210-019-01687-2. Epub 2019 Jul 10.
2
Euxanthone inhibits glycolysis and triggers mitochondria-mediated apoptosis by targeting hexokinase 2 in epithelial ovarian cancer.柚皮素通过靶向作用于上皮性卵巢癌细胞中的己糖激酶 2 抑制糖酵解并触发线粒体介导的细胞凋亡。
Cell Biochem Funct. 2018 Aug;36(6):303-311. doi: 10.1002/cbf.3349. Epub 2018 Jul 8.
3
Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells.阿帕替尼通过抑制卵巢癌细胞中的 VEGFR2/AKT1/SOX5/GLUT4 信号通路来抑制糖酵解。
Cell Oncol (Dordr). 2019 Oct;42(5):679-690. doi: 10.1007/s13402-019-00455-x. Epub 2019 Jul 20.
4
Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway.白藜芦醇通过抑制糖酵解和靶向 AMPK/mTOR 信号通路抑制卵巢癌细胞增殖并诱导其凋亡。
J Cell Biochem. 2018 Jul;119(7):6162-6172. doi: 10.1002/jcb.26822. Epub 2018 Apr 16.
5
Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.蟾毒灵可诱导人子宫内膜癌细胞和卵巢癌细胞生长抑制、细胞周期阻滞及凋亡。
Int J Mol Med. 2008 May;21(5):637-43.
6
PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma.PIM1调节糖酵解并促进肝细胞癌的肿瘤进展。
Oncotarget. 2015 May 10;6(13):10880-92. doi: 10.18632/oncotarget.3534.
7
PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.PIM1 在 T 细胞淋巴瘤中的过表达通过上调 c-myc 表达来保护肿瘤细胞免于凋亡并赋予阿霉素耐药性。
Acta Biochim Biophys Sin (Shanghai). 2018 Aug 1;50(8):800-806. doi: 10.1093/abbs/gmy076.
8
PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells.PIM1 激酶抑制剂可诱导非小细胞肺癌细胞放射增敏。
Pharmacol Res. 2013 Apr;70(1):90-101. doi: 10.1016/j.phrs.2013.01.005. Epub 2013 Jan 23.
9
The Natural Compound Myricetin Effectively Represses the Malignant Progression of Prostate Cancer by Inhibiting PIM1 and Disrupting the PIM1/CXCR4 Interaction.天然化合物杨梅素通过抑制PIM1并破坏PIM1/CXCR4相互作用有效抑制前列腺癌的恶性进展。
Cell Physiol Biochem. 2018;48(3):1230-1244. doi: 10.1159/000492009. Epub 2018 Jul 25.
10
Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.人参皂苷20(S)-Rg3阻止靶向PKM2的miR-324-5p被H19吸附,以拮抗卵巢癌细胞中的瓦伯格效应。
Cell Physiol Biochem. 2018;51(3):1340-1353. doi: 10.1159/000495552. Epub 2018 Nov 27.

引用本文的文献

1
Cardenolide glycosides sensitize gefitinib-induced apoptosis in non-small cell lung cancer: inhibition of Na/K-ATPase serving as a switch-on mechanism.卡烯内酯糖苷增敏吉非替尼诱导非小细胞肺癌细胞凋亡:钠钾-ATP 酶抑制作为一种开关机制。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):6533-6550. doi: 10.1007/s00210-024-03031-9. Epub 2024 Mar 7.
2
Enhancement of Dissolving Capacity and Reducing Gastric Mucosa Irritation by Complex Formation of Resibufogenin with β-Cyclodextrin or 2-Hydroxypropyl-β-cyclodextrin.通过与 β-环糊精或 2-羟丙基-β-环糊精形成复合物来增强瑞马布芬的溶解能力并降低其对胃黏膜的刺激性。
Molecules. 2022 May 17;27(10):3213. doi: 10.3390/molecules27103213.

本文引用的文献

1
1,25-(OH)D protects Schwann cells against advanced glycation end products-induced apoptosis through PKA-NF-κB pathway.1,25-(OH)D 通过 PKA-NF-κB 通路保护施万细胞免受晚期糖基化终产物诱导的细胞凋亡。
Life Sci. 2019 May 15;225:107-116. doi: 10.1016/j.lfs.2019.03.068. Epub 2019 Mar 27.
2
Lactate production without hypoxia in skeletal muscle during electrical cycling: Crossover study of femoral venous-arterial differences in healthy volunteers.在健康志愿者中,电循环期间骨骼肌在非缺氧状态下产生乳酸:股静脉-动脉差别的交叉研究。
PLoS One. 2019 Mar 1;14(3):e0200228. doi: 10.1371/journal.pone.0200228. eCollection 2019.
3
Effects of CytoReductive surgery plus hyperthermic IntraPEritoneal chemotherapy (HIPEC) versus CytoReductive surgery for ovarian cancer patients: A systematic review and meta-analysis.
细胞减灭术联合腹腔热灌注化疗(HIPEC)与细胞减灭术治疗卵巢癌患者的效果:系统评价和荟萃分析。
Eur J Surg Oncol. 2019 Mar;45(3):301-309. doi: 10.1016/j.ejso.2018.10.528. Epub 2018 Oct 24.
4
PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway.PIM1 激酶通过增强 c-MET 信号通路促进肺腺癌的细胞增殖、转移和肿瘤生长。
Cancer Lett. 2019 Mar 1;444:116-126. doi: 10.1016/j.canlet.2018.12.015. Epub 2018 Dec 21.
5
Downregulation of PIM1 regulates glycolysis and suppresses tumor progression in gallbladder cancer.PIM1的下调调节糖酵解并抑制胆囊癌的肿瘤进展。
Cancer Manag Res. 2018 Oct 30;10:5101-5112. doi: 10.2147/CMAR.S184381. eCollection 2018.
6
Pim1 promotes cell proliferation and regulates glycolysis via interaction with MYC in ovarian cancer.Pim1通过与卵巢癌中的MYC相互作用促进细胞增殖并调节糖酵解。
Onco Targets Ther. 2018 Oct 9;11:6647-6656. doi: 10.2147/OTT.S180520. eCollection 2018.
7
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response.靶向 PIM 激酶联合 PD1 抑制增强免疫治疗抗肿瘤 T 细胞反应。
Clin Cancer Res. 2019 Feb 1;25(3):1036-1049. doi: 10.1158/1078-0432.CCR-18-0706. Epub 2018 Oct 16.
8
Cinobufacini Injection Improves the Efficacy of Chemotherapy on Advanced Stage Gastric Cancer: A Systemic Review and Meta-Analysis.华蟾素注射液提高晚期胃癌化疗疗效:一项系统评价与Meta分析
Evid Based Complement Alternat Med. 2018 Sep 4;2018:7362340. doi: 10.1155/2018/7362340. eCollection 2018.
9
Resibufogenin suppresses transforming growth factor-β-activated kinase 1-mediated nuclear factor-κB activity through protein kinase C-dependent inhibition of glycogen synthase kinase 3.瑞舒伐他汀通过蛋白激酶 C 依赖性抑制糖原合酶激酶 3 抑制转化生长因子-β激活激酶 1 介导的核因子-κB 活性。
Cancer Sci. 2018 Nov;109(11):3611-3622. doi: 10.1111/cas.13788. Epub 2018 Sep 23.
10
Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells.隐丹参酮通过 STAT3/SIRT3 信号通路抑制卵巢癌细胞的增殖和葡萄糖代谢。
Cancer Med. 2018 Sep;7(9):4610-4618. doi: 10.1002/cam4.1691. Epub 2018 Aug 9.